The Effect of an Experimental Gel Based on Acmella Oleracea Extract in Reducing Post-bleaching Tooth Sensitivity

Sponsor
Universidade Federal do Para (Other)
Overall Status
Completed
CT.gov ID
NCT05725850
Collaborator
(none)
50
1
2
1.6
30.4

Study Details

Study Description

Brief Summary

This randomized, double-blind clinical trial aimed to evaluate the effect of an experimental gel containing 10% jambu extract (Acmella Oleracea) in reducing postoperative tooth sensitivity caused by bleaching with 35% hydrogen peroxide. The volunteers of this study were randomized into two different groups - GE (A. Oleracea extract at 10%) and GP (placebo). The dental elements of the GE received application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes. The GP group also received the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel. Subsequently, all groups underwent in-office bleaching treatment with 35% hydrogen peroxide.Post-bleaching sensitivity was collected through a form composed of the visual analogue scale (VAS). Color measurement was performed at two times: baseline (Ti) and one week after the 3rd bleaching session (Tf).

Condition or Disease Intervention/Treatment Phase
  • Other: EG (Experimental A. Oleracea extract gel)
  • Other: GP (Gel placebo)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Effect of an Experimental Gel Based on Jambu Extract ( Acmella Oleracea) in Reducing Post-bleaching Tooth Sensitivity : a Randomized Clinical Study
Actual Study Start Date :
Nov 7, 2022
Actual Primary Completion Date :
Dec 27, 2022
Actual Study Completion Date :
Dec 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: EG (Experimental A. Oleracea extract gel)

The EG group received the application of experimental gel of A. Oleracea extract for post tooth bleaching sensitivity.

Other: EG (Experimental A. Oleracea extract gel)
Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the EG received application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.

Placebo Comparator: GP (Gel placebo)

The GP group received the application of a placebo gel.

Other: GP (Gel placebo)
Prior to bleaching treatment with 35% hydrogen peroxide, the GP group also received the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.

Outcome Measures

Primary Outcome Measures

  1. Assessment of post bleaching sensitivity [21 days]

    For the assessment of postoperative sensitivity, patients were instructed to fill out a form to record tooth sensitivity daily, during the 21 days of treatment, based on individual pain perception. This form was delivered at each bleaching session, being returned to the researcher in the following session, that is, always one week after each bleaching session. The evaluation form consisted of the visual analogue scale (VAS). This scale consists of a 10 cm horizontal line, with scores of 0 and 10 at its ends, where 0 means no sensitivity and 10 means severe tooth sensitivity. The patient was instructed to draw a vertical line along the horizontal line of the scale, recording the intensity of tooth sensitivity per day. So that the distance in millimeters from the zero end could be later measured with the aid of a millimeter ruler, thus obtaining the patient's level of pain intensity.

Secondary Outcome Measures

  1. Color evaluation [Baseline (Ti) and one week after the 3rd whitening session (Tf).]

    The VITA Easyshade spectrophotometer (VITA Zahnfabrik, Bad Säckingen, Germany) was used to measure the color, where the area of dental correspondence to be evaluated was the middle third of the buccal surface of the upper canines. To standardize the color readings, silicone trays were made, where the impression was extended from canine to canine. A window was created on the buccal surface of each canine of the silicone guide using a metal device with a 6 mm radius, corresponding to the diameter of the spectrophotometer tip. Thus, the tip of the device was inserted into the silicone guide to obtain the color parameters. Subsequently, the color difference between baseline (T i ) and one week after the 3rd bleaching session (T f ) was calculated using the CIEDE2000 formulas (ΔE00).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • good oral hygiene

  • absence of active caries lesions

  • never having undergone previous whitening therapy

  • not present dental hypersensitivity

  • don't be a smoker

  • not be pregnant

  • present at least 28 teeth in the oral cavity.

Exclusion Criteria:
  • volunteers who were under orthodontic treatment,

  • presence of periodontal disease

  • dental cracks or fractures

  • restorations and prostheses on anterior teeth

  • extensive molar restorations

  • gastroesophageal disorders

  • severe internal dental darkening

  • presence of dentinal exposure in anterior and / or posterior teeth.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Federal University of Para Belém PA Brazil 66075-110

Sponsors and Collaborators

  • Universidade Federal do Para

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cecy Martins Silva, Professor of the Graduate Program in Dentistry at the Federal University of Pará, Universidade Federal do Para
ClinicalTrials.gov Identifier:
NCT05725850
Other Study ID Numbers:
  • UFPara-015
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023